Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
)'s Drug for Nerve Pain, Lyrica Gets Expanded Approval In Japan
10/29/2010 6:46:04 AM
Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.
Cuts Deal With
(PFE), Four Other Pharmas, For Antibody Drug Discovery Tool in Deal Worth up to $50 Million
Approval for a Second-Generation Hepatitis C Viral Load Test
(PFE) to Buy Stake In Brazil's
for $240 Million
Dainippon Sumitomo Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc.
(SEPR)'s Schizophrenia Pill, Latuda Gets
Italy Antitrust Probes
(PFE) Over Xalatan
Bristol-Myers Squibb Company
(BMY) Cancer Drug, Sprycel Receives New Approval
(PFE) Hormone, Prempro Almost Double Breast Cancer Death Risk in U.S. Research
Narcotics and Diagnostics Overused in Treatment of Chronic Neck Pain
(PFE)'s New Drug, Crizotinib Shows Promise Against Certain Lung Cancers
Narcotics and Diagnostics Overused in Treatment of Chronic Neck Pain,
University of North Carolina
comments powered by Disqus.
comments powered by
Clinical - Approvals
Clinical - Approvals (World)